{"schema_version":"secwatch.filing_event.v1","accession":"0001837607-26-000055","form_type":"8-K","ticker":"AEON","cik":"0001837607","company_name":"AEON Biopharma, Inc.","filed_at":"2026-07-23T20:01:19+00:00","discovered_at":"2026-07-23T20:02:00.265767+00:00","generated_at":"2026-07-23T20:02:15.983805+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"AEON Biopharma issues 4.7M shares in partial over-allotment exercise, raising $1.5M gross","bullets":["On July 23, 2026, issued 4,696,102 shares of Class A common stock to underwriters.","Gross proceeds of approximately $1.5 million; net proceeds of ~$1.4 million after underwriting discounts.","Partial exercise of over-allotment option; previous full exercise for warrants to purchase 6,403,290 shares.","Offering originally completed July 15, 2026, with Lake Street Capital Markets as representative."],"urls":{"canonical":"https://secwatch.observer/filing/0001837607-26-000055","json":"https://secwatch.observer/filing/0001837607-26-000055.json","markdown":"https://secwatch.observer/filing/0001837607-26-000055.md","text":"https://secwatch.observer/filing/0001837607-26-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/0001837607-26-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/aeon-20260723x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T20:02:15.983805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}